Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter

1 Jan 2019

Abstract excerpt

: Based on these results, the CDYL/EZH2/CDKN1C axis promotes chemoresistance in SCLC, and these markers represent promising therapeutic targets for overcoming chemoresistance in patients with SCLC.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31367252
DOI: 10.7150/thno.33680

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoterPMID 31367252Read ↗

PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancerSemantic proximity Read ↗

FOXM1 targeting alters AURKB activity and reshapes antitumor immunity to curb the progression of small cell lung cancerSemantic proximity Read ↗

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2Semantic proximity Read ↗

DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progressionSemantic proximity Read ↗

Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylationSemantic proximity Read ↗

Aberrant Methylation Modifications Reflect Specific Drug Responses in Small Cell Lung CancerSemantic proximity Read ↗

Abnormal genome-wide DNA methylation induced by cisplatin may contribute to the chemo-resistance of human small cell lung cancerSemantic proximity Read ↗

Unravelling the biology of SCLC: implications for therapy.Semantic proximity Read ↗

NCAPD2 Is a Favorable Predictor of Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Lung CancerSemantic proximity Read ↗

BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 TransactivationSemantic proximity Read ↗

KDM7B-mediated demethylation of RNF113A regulates small cell lung cancer sensitivity to alkylation damageSemantic proximity Read ↗

FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.